Periscope Capital’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Periscope Capital’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-91,916	Closed	-$5K	–	245
2020 Q1	$5K	Hold	91,916	–	–	﹤0.01%	242
2019 Q4	$16K	Hold	91,916	–	–	﹤0.01%	236
2019 Q3	$15K	Sell	91,916 -15,584	-14%	-$3.04K	﹤0.01%	225
2019 Q2	$23K	Hold	107,500	–	–	﹤0.01%	203
2019 Q1	$19K	Buy	107,500 +6,700	+7%	+$1.69K	﹤0.01%	166
2018 Q4	$38K	Hold	100,800	–	–	0.01%	159
2018 Q3	$42K	Hold	100,800	–	–	0.01%	157
2018 Q2	$38K	Buy	100,800 +50,400	+100%	+$23.1K	0.01%	157
2018 Q1	$19K	Buy	+50,400	New	+$19.8K	﹤0.01%	148

Other funds holding NRXPW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

VAS

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Periscope Capital's NRXPW Position: Q2 2020 in Review

Periscope Capital sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2020, closing a stake of 91,916 shares — an estimated $5K sold.

Periscope Capital first reported a position in NRXPW in Q1 2018 and held it in 9 quarters. The position peaked at $42K in Q3 2018. 13 funds tracked by Wall St. Rank hold NRXPW as of Q2 2020.

Periscope Capital reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2020 after selling out during the quarter.
Periscope Capital sold 91,916 NRX Pharmaceuticals Warrant shares in Q2 2020, an estimated $5K.
Periscope Capital first reported a position in NRX Pharmaceuticals Warrant in Q1 2018 and held it in 9 quarters.
Periscope Capital's NRX Pharmaceuticals Warrant position peaked at $42K in Q3 2018.
13 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2020.

Based on Periscope Capital's 13F filing for Q2 2020, filed 11 Aug 2020.